MER-XMT-1660-1
A PHASE 1B, FIRST IN HUMAN, DOSE ESCALATION AND EXPANSION, MULTICENTER STUDY OF XMT- 1660 IN PARTICIPANTS WITH SOLID TUMORS
COVID-19: We are currently offering vaccinations to current qualifying patients. CURRENT PATIENTS VACCINATION INFO.
A PHASE 1B, FIRST IN HUMAN, DOSE ESCALATION AND EXPANSION, MULTICENTER STUDY OF XMT- 1660 IN PARTICIPANTS WITH SOLID TUMORS
Learn more about our Cancer Treatment Team by scrolling below, or visit our Meet the Team page.